首頁 › 非小細胞肺癌 › 加州 › Mountain View
Mountain View, CA 的 非小細胞肺癌 臨床試驗
21 項針對 非小細胞肺癌 的研究正在 Mountain View（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Safety and Efficacy of OBX-115 in Advanced Solid Tumors
招募中1/2 期
- Stanford Cancer Institute (Melanoma/NSCLC), Stanford · 距離 5 英里
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
招募中3 期
- Palo Alto Medical Foundation-Camino Division, Mountain View
- Palo Alto Medical Foundation Health Care, Palo Alto · 距離 5 英里
- Stanford Cancer Institute Palo Alto, Palo Alto · 距離 5 英里
Adaptive ctDNA-Based Personalization of Treatment During Consolidation Therapy in NSCLC
招募中3 期
- Stanford University, Stanford · 距離 5 英里
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
招募中2 期
- Stanford Cancer Institute, Stanford · 距離 5 英里
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
招募中觀察性研究
- Stanford University, Palo Alto · 距離 5 英里
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
招募中2 期
- Stanford Cancer Institute, Stanford · 距離 5 英里
- Stanford Hospital and Clinics, Stanford · 距離 5 英里
- Stanford Hospital Investigational Drug Services, Stanford · 距離 5 英里
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
招募中3 期
- Stanford Cancer Center, Palo Alto · 距離 5 英里
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
招募中1/2 期
- Stanford Cancer Institute, Stanford · 距離 5 英里
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
招募中1/2 期
- Stanford University Medical Center - Neurology, Stanford · 距離 5 英里
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
招募中3 期
- Palo Alto Medical Foundation Research Center, Palo Alto · 距離 5 英里
A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)
招募中1/2 期
- Stanford Cancer Institute, Stanford · 距離 5 英里
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
招募中1/2 期
- Stanford University Medical Center, Stanford · 距離 5 英里
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
招募中1 期
- Stanford University Medical Center, Palo Alto · 距離 5 英里
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
招募中1 期
- Stanford University, Palo Alto · 距離 5 英里
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
招募中1/2 期
- Stanford University - Stanford Cancer Institute, Stanford · 距離 5 英里
A Study of LY4175408 in Participants With Advanced Cancer
招募中1 期
- Stanford Medicine Cancer Center, Stanford · 距離 5 英里
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
招募中1/2 期
- Stanford University, Stanford · 距離 5 英里
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
招募中1/2 期
- Stanford Women's Cancer Center, Palo Alto · 距離 5 英里
Engagement of Veterans With Lung Cancer
招募中
- Veterans Affairs Palo Alto Health Care System (VAPAHCS), Palo Alto · 距離 5 英里
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中觀察性研究
- Massive Bio SYNERGY-AI site, Stanford · 距離 5 英里
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
招募中1 期
- Stanford University, Stanford · 距離 5 英里
其他城市的 非小細胞肺癌 試驗
- Houston, TX145 項研究
- New York City, NY121 項研究
- Arlington, VA104 項研究
- Nashville, TN97 項研究
- Boston, MA90 項研究
- Los Angeles, CA87 項研究
- St. Louis, MO73 項研究
- Chicago, IL61 項研究
- Baltimore, MD60 項研究
- San Antonio, TX59 項研究
- Columbus, OH57 項研究
- Washington, DC55 項研究
Mountain View 的其他研究
- 癌症（所有類型）40 項研究
- 乳癌26 項研究
- 轉移性癌症25 項研究
- 急性髓系白血病19 項研究
- 卵巢癌19 項研究
- 自閉症譜系障礙17 項研究
- 肺癌17 項研究
- 前列腺癌15 項研究
- 心臟衰竭15 項研究
- 自閉症13 項研究
- 急性淋巴母細胞性白血病13 項研究
- 大腸直腸癌13 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。